Online Reporter
Mabasa Sasa and Forward Nyanyiwa
THE Government’s decision to decline a proposed health cooperation pact with the United States has triggered animated debate in policy circles and on social media.
Predictably, some have framed the development as a diplomatic rupture.
Others have cast it as an ideological standoff.
It is neither.
At its core, the issue speaks to sovereignty, prudence and the long-term architecture of Zimbabwe’s public health financing model.
Amidst reports that Zambia also turned down a similar American proposal and murmurs that the United Kingdom, too, raised concerns around health data access, it becomes clear that this is not something peculiar to Zimbabwe.
It is part of a broader recalibration taking place across nations that are increasingly alert to the strategic value of data and natural resources.
The conversation we must now have is not about what Zimbabwe rejected, but about what Zimbabwe must build.
Health cooperation, in principle, is welcome.
Zimbabwe has historically engaged multilaterally and bilaterally in the fight against HIV and AIDS, tuberculosis, malaria and, more recently, Covid-19. But cooperation must be structured carefully.
Health data today is not a mere administrative tool.
It is demographic intelligence, epidemiological mapping and, increasingly, a strategic asset.
In a world where data drives pharmaceutical research, insurance modelling and even geopolitical leverage, nations are understandably cautious about unfettered access to such information.
Equally sensitive are any linkages between humanitarian cooperation and access to strategic minerals.
Zimbabwe, like many African states, is endowed with critical minerals that are central to global industrial and technological supply chains. To conflate health cooperation with mineral access would blur lines that ought to remain distinct.
If concerns were raised on those grounds, caution was justified.
Sovereignty demands nothing less.
Beyond aid: Financing our own health future
Yet the real story lies not in the refusal of an external pact, but in Zimbabwe’s evolving internal posture.
The Covid-19 pandemic delivered a sobering lesson to the developing world: When crisis strikes, global solidarity has limits. Export bans were imposed. Vaccine nationalism took centre stage. Supply chains fractured.
For African countries, access to essential medical commodities became a waiting game.
That experience underscored the necessity of what can best be described as healthcare sovereignty: the ability to safeguard public health regardless of shifting external dynamics.
Encouragingly, Zimbabwe has begun to institutionalise that lesson.
Through the 2026 National Budget, the country met the 15 percent public health financing threshold set by the African Union under the Abuja Declaration.
In doing so, Zimbabwe joined Rwanda and Botswana as one of only three African countries to have attained that benchmark.
For years, the Abuja target was more aspirational than actual. Meeting it signals intent and seriousness on the part of President Mnangagwa’s administration. But intent must now translate into execution.
Allocations on paper must result in functioning hospitals, stocked pharmacies, equipped laboratories and motivated health professionals. Fiscal discipline and transparency will be critical.
Lessons from recent history
It is worth recalling that around 2024, American health financing to several countries underwent freezes and recalibrations. Zimbabwe’s health system did not collapse in that period.
It adapted.
Treasury support was strengthened. The private sector played a greater role. Diaspora remittances quietly underpinned household health expenditures.
Multilateral relationships were recalibrated. The system was strained — but it endured.
That endurance is instructive. It demonstrates that while external funding can be catalytic, it is not the sole pillar upon which our health architecture rests.
The strategies deployed during that period should now be refined and institutionalised into a coherent long-term financing model.
In recent years, Zimbabwe has demonstrated a capacity to mobilise domestic resources for large-scale infrastructure.
Major highways have been rehabilitated and expanded through locally structured financing mechanisms and executed by Zimbabwean engineers and firms. That same determination can be applied to health.
Hospitals, oxygen plants (for example, Verify Engineering’s infrastructure), diagnostic centres and pharmaceutical facilities are as strategic as roads.
If we can innovate around infrastructure bonds and domestic financing instruments for transport networks, we can do likewise for health infrastructure.
The principle is identical: national priorities should be funded through national ingenuity.
Africa’s pharmaceutical paradox
The continental dimension must also be confronted candidly.
Africa, with a population of 1,3 billion and a combined economy exceeding US$1 trillion, remains heavily dependent on imported medicines.
Estimates suggest that between 70 and 80 percent of pharmaceuticals consumed on the continent are imported.
Prior to Covid-19, Africa accounted for less than 1 percent of global vaccine production.
This imbalance persists despite the continent’s role as a major supplier of raw materials critical to global pharmaceutical and medical manufacturing value chains. The paradox is stark: Africa exports inputs and imports finished products — often at a premium.
If healthcare sovereignty is to move beyond slogans, this structure must change.
Synergies across African states are essential.
One country may host mineral inputs; another may possess chemical processing capacity; another may have regulatory strength; yet another may offer a sizeable consumer market.
Coordinated industrial policy can create a continental pharmaceutical ecosystem that reduces vulnerability to external shocks.
Zimbabwe, with its skilled human capital base, can position itself strategically within such a value chain, particularly in research, clinical trials and health informatics.
During Covid-19, SADC made encouraging noises about such a strategy.
With Trump putting America first, surely, SADC and Africa at large should start putting their citizens first.
Perhaps the most under-appreciated asset in this conversation is demographic.
Africa is the youngest continent in the world.
Zimbabwe’s population is predominantly youthful. Within that demographic reality lies immense creative and technological potential.
Innovative financing models for health need not mirror those of the past.
Mobile money platforms can support micro-insurance schemes.
Diaspora bonds can be structured specifically for hospital modernisation.
Digital health platforms can reduce inefficiencies and leakages.
Artificial intelligence can enhance disease surveillance and resource allocation.
These solutions must not be imported wholesale.
They must be designed locally, informed by local realities and driven by local talent.
Healthcare sovereignty, ultimately, is about agency: The confidence to craft solutions grounded in our own context.
Measured resolve
The collapse of the proposed US pact is not a catastrophe.
It is a moment of clarity.
Zimbabwe has demonstrated that it can meet continental commitments on health financing. It has demonstrated resilience in the face of funding recalibrations.
It has demonstrated, in other sectors, the capacity to mobilise domestic resources for strategic infrastructure.
The task now is consolidation.
International partnerships will remain important, and Zimbabwe must continue to engage constructively with all nations on the basis of mutual respect and transparency.
Global health challenges do not recognise borders. But cooperation must reinforce — not dilute — sovereignty.
In the final analysis, the measure of a nation’s independence is not in the number of agreements it signs, but in its capacity to safeguard the wellbeing of its people under all circumstances.
Zimbabwe stands at such a juncture.
The choices made today — in budgeting, in industrial policy and technological innovation — will determine whether healthcare sovereignty becomes a lived reality or an aspirational phrase.
The opportunity is before us.
The responsibility is ours.
Mabasa Sasa is the former Editor of The Sunday Mail, while Forward Nyanyiwa is a qualified general nurse and an award-winning health journalist based in Carlow, Ireland.
Tinaye Agere